CONTEPO Trademark

Trademark Overview


On Tuesday, June 13, 2023, a trademark application was filed for CONTEPO with the United States Patent and Trademark Office. The USPTO has given the CONTEPO trademark a serial number of 98039678. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, June 3, 2025. This trademark is owned by Zavante Therapeutics, Inc.. The CONTEPO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, anti-infectives; antibiotics; pharmaceuticals for the treatment of urinary tract infections
contepo

General Information


Serial Number98039678
Word MarkCONTEPO
Filing DateTuesday, June 13, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Description of MarkThe mark consists of of the stylized wording "CONTEPO" appearing on the left side of the mark with a design appearing on the right side of the mark consisting of concentric circles with the interior circle dissolving into a circle dot pattern extending beyond the left perimeter of the concentric circles with two circles appearing over the last letter "O" in "CONTEPO".
Goods and ServicesPharmaceuticals, namely, anti-infectives; antibiotics; pharmaceuticals for the treatment of urinary tract infections
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "CONTEPO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMEITHEAL PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCHICAGO, IL 60631

Party NameZavante Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Washington,, PA 19406

Party NameZavante Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Washington,, PA 19406

Trademark Events


Event DateEvent Description
Tuesday, March 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 16, 2023NEW APPLICATION ENTERED
Monday, July 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 18, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 4, 2024ASSIGNED TO EXAMINER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 26, 2024SOU EXTENSION 1 FILED
Thursday, August 22, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 26, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 3, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, June 3, 2025SOU EXTENSION 2 FILED
Tuesday, June 3, 2025SOU EXTENSION 2 GRANTED
Tuesday, November 26, 2024SOU EXTENSION 1 GRANTED